Rheumatoid arthritis and osteoarthritis patients can experience poorly controlled severe type 2 diabetes, say French researchers who suggest considering targeting insulin resistance through treatment for joint and systemic inflammation.
Patients with type 2 diabetes face up to a three-fold increased risk of hip fracture, despite adequate areal bone mineral density which may underestimate fracture risk in these patients.
In addition to a diabetes diagnosis, people with a history of smoking and who have specific comorbidities, such as heart disease, liver disease, and chronic lower respiratory disease, are at increased risk of poorer COVID-19 outcomes.
The Endocrine Society is calling for immediate action by policymakers to address the underlying factors responsible for the rising cost of insulin, a life-saving drug taken by 7.4 million people in the United States.
The severity of complications from diabetes appear to differ by race and ethnicity.
In a statement published in the Journal of Clinical Endocrinology and Metabolism, physicians from Johns Hopkins School of Medicine acknowledge the challenges minority populations may face within the healthcare system. They pose a larger question: Why does disparity exist?
Study researchers evaluated whether hypertension and prehypertension could predict greater decline in cognitive performance.
Fasting glucose levels and glycemic fluctuations have been found to be independently associated with poor prognosis in adults hospitalized for COVID-19—regardless of diabetes status.
Monitoring changes at 2 retinal biomarkers, OCT-A can foretell visual outcomes and retinal sensitivity.
A deeper insight into the association between treatment with biologic disease-modifying antirheumatic drugs in rheumatic diseases and risk for type 2 diabetes.
